CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(285 sites)

United States

Mayo Clinic Hospital, Phoenix, Arizona

University of California San Diego (UCSD) - Sulpizio Cardiovascular Center (SCVC), La Jolla, California

Keck School of Medicine USC - Healthcare Consultation Center 2 (HCCII), Los Angeles, California

Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California

UCI Medical Center, Orange, California